Forecast & RatingOnly 1 analyst currently covers Telomir Pharmaceuticals (TELO.US), with a price target of $15.50. The sample is very small, so treat this as a reference only. Data as of Jan 6, 2026; this does not constitute investment advice.
Sep 9, 2025
Price forecast
$15.501160.16%
Forecast & Rating-
0analysts
Target price forecast
Forecast baselineJul 26, 2026
Forecast met0.0%
Stock price$1.23
Average forecast price$15.5
Highest forecast price$16
Lowest forecast price$16
Average forecast price
$15.5
Highest forecast price
$16
Lowest forecast price
$16
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.